Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Galapagos
Galapagos
Galapagos' osteoarthritis drug flunks phase 2, dashing hopes of $250M Gilead deal
Fierce Biotech
Fri, 10/16/20 - 11:11 am
Galapagos
Servier
GLPG1972
osteoarthritis of the knee
clinical trials
Gilead and Galapagos's filgotinib shows sustained efficacy in ulcerative colitis study
Seeking Alpha
Tue, 10/13/20 - 11:17 am
filgotinib
Gilead Sciences
Galapagos
clinical trials
ulcerative colitis
Go or no go? Valuable drugs set for FDA decisions
EP Vantage
Wed, 07/29/20 - 10:54 am
FDA
drug approvals
Novartis
inclisiran
Biomarin
valrox
Roche
risdiplam
GSK
belantamab mafodotin
Gilead Sciences
Galapagos
filgotinib
3 Biotech Stocks With Big Incoming Catalysts
Motley Fool
Sat, 07/25/20 - 02:25 pm
FDA
GW Pharma
Epidiolex
filgotinib
Galapagos
Biomarin
valoctocogene roxaparvovec
Go or no go? Pandemic looms over FDA timelines
EP Vantage
Wed, 07/1/20 - 10:54 am
Jazz Pharma
Gilead Sciences
Galapagos
GSK
FDA
pandemic
COVID-19
Gilead builds case for filgotinib in active psoriatic arthritis
Fierce Biotech
Mon, 06/8/20 - 10:38 am
Gilead Sciences
Galapagos
filgotinib
clinical trials
psoriatic arthritis
Gilead shows durability of filgotinib ahead of face-off with AbbVie
Fierce Biotech
Thu, 06/4/20 - 11:00 am
Gilead Sciences
Galapagos
clinical trials
filgotinib
rheumatoid arthritis
Galapagos finds little comfort in safety
EP Vantage
Fri, 05/22/20 - 10:28 am
Galapagos
filgotinib
ulcerative colitis
Gilead's filgotinib phase 3 hits primary endpoint but details dampen hopes
Fierce Biotech
Thu, 05/21/20 - 10:28 am
Gilead Sciences
Galapagos
filgotinib
ulcerative colitis
clinical trials
Big pharma heads towards important readouts
EP Vantage
Wed, 05/20/20 - 10:22 am
Ozempic
Novo Nordisk
etrolizumab
Roche
Ipatasertib
finerenone
Bayer
filgotinib
Gilead Sciences
Galapagos
Avalglucosidase alfa
Sanofi
Rinvoq
AbbVie
clinical trials
Galapagos CEO talks next steps as coronavirus stalls the biotech's top drug
BioPharma Dive
Wed, 03/25/20 - 11:41 pm
Galapagos
Gilead Sciences
filgotinib
rheumatoid arthritis
FDA
COVID-19
Lilly, Galapagos halt trials as coronavirus deepens impact on drug research
BioPharma Dive
Mon, 03/23/20 - 12:00 pm
Eli Lilly
Galapagos
ObsEva
clinical trials
COVID-19
Gilead/Galapagos, Intercept and Corbus trials could be hit by coronavirus spread: analyst
Fierce Biotech
Wed, 03/11/20 - 10:55 am
clinical trials
Gilead Sciences
Galapagos
Corbus Pharmaceuticals
Intercept Pharmaceuticals
coronaviruses
COVID-19
Upcoming events – Filgotinib's ulcerative colitis data and serlopitant takes on pruritus
EP Vantage
Fri, 02/21/20 - 10:35 am
Gilead Sciences
Galapagos
filgotinib
ulcerative colitis
Menlo Therapeutics
serlopitant
Galapagos bags option on 4 more Fibrocor programs
Fierce Pharma
Wed, 01/15/20 - 10:54 am
Galapagos
fibrosis
Fibrocor
As promised, Gilead and Galapagos file filgotinib to FDA and get a speedy review
Fierce Biotech
Fri, 12/20/19 - 12:29 pm
Gilead Sciences
FDA
filgotinib
Galapagos
rheumatoid arthritis
Trials of Novartis' Dupixent rival bet scrapped by MorphoSys, Galapagos
Fierce Biotech
Tue, 10/29/19 - 09:57 am
MorphoSys
Galapagos
Novartis
MOR106
atopic dermatitis
Dupixent
Sanofi
Gilead, Galapagos share 52-week update on filgotinib
Fierce Biotech
Fri, 10/11/19 - 10:44 am
Gilead Sciences
Galapagos
filgotinib
clinical trials
rheumatoid arthritis
Biopharma M&A: deal-depressed third quarter leaves nowhere to hide
EP Vantage
Tue, 10/8/19 - 10:53 am
M&A
Lundbeck
Alder Biopharmaceuticals
Gilead Sciences
Galapagos
Vertex Pharmaceuticals
Semma
Swedish Orphan Biovitrum
Dova Pharmaceuticals
Novartis
IFM
Chasing AbbVie, Gilead files for approval of filgotinib in Japan
Fierce Biotech
Tue, 10/8/19 - 09:40 am
Gilead Sciences
JAK inhibitors
Japan
filgotinib
Galapagos
AbbVie
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »